Why is the Novonix (ASX:NVX) share price in a trading halt today?

The Novonix (ASX: NVX) share price is in a trading halt today as the company announced a capital raising and its half year report.

| More on:
asx share price trading halt represented by stop sign

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Novonix Ltd (ASX: NVX) share price was in a trading halt today on news the company plans to undertake a capital raising. The graphite producer also released its half-year report today for the period ending 31 December 2020.

At the time of writing, the Novonix share price remains suspended at yesterday's closing price of $3.29.

It has been a positive year thus far for the company as its shares have soared an astounding 165%. Let's unpack the latest announcements.

Novonix half-year report

Novonix reported depressed revenue for the half-year as the coronavirus pandemic impacted results. As such, revenue from ordinary activities decreased by 6% from $2.9 million to $2.734 million. Moreover, the company saw a widening loss as operating expenses increased. To this point, the loss increased by 53% to $10.767 million.

During the period, the company continued strong growth in research and development services with tier 1 clients. This was highlighted as Novonix continued research progress through a partnership with Professor Mark Obrovac working on new IP development.

Regarding the company's financials, Novonix currently holds $25.28 million in cash, down significantly from the $38.8 million held at the end of FY20.

Capital raising

The Novonix share price is in a trading halt today after the company announced an equity raising. A fully underwritten placement to raise approximately $115 million to institutional investors will close on 26 February.

The company will use net proceeds to fund expansion in capital expenditure and working capital to scale its anode materials production to 10,000 tonnes per annum. The increase comes under an exclusive technology alliance announced in December with US-based thermal processing solutions expert, Harper International Corporation.

This will include a new manufacturing site expansion, along with infrastructure and equipment being commissioned over the next 24 months, as well as working capital associated with increased production levels.

The placement offer price is $2.90 per share. This represents an 11.9% discount to the last traded price of its shares ($3.29).

Furthermore, the company will begin a share purchase plan (SPP) on 4 March. Eligible shareholders will be able to subscribe for up to $10,000 worth. The SPP aims to raise approximately $15 million.

Management comments

Commenting on the capital raising, Novonix chair Tony Bellas said:

It is an exciting time for the company as it begins to rapidly scale production of high-performance anode materials for lithium ion batteries to meet the growing demands of the electric vehicle (EV) and energy storage system (ESS) markets in North America.

The company remains well positioned as the only qualified producer in North America of high grade anode material suitable for lithium ion batteries for EVs and ESS. Importantly, the company is continuing to strengthen its position with key relationships across the industry such as Harper International to develop next generation furnace technology systems.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »

Magnifying glass on a rising interest rate graph.
Share Market News

Will the RBA finally cut interest rates next week?

Let's see what economists are saying about the central bank's meeting.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors endured a rough Friday to close the trading week today.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Broker Notes

7 ASX All Ords shares elevated to 'strong buy' status in October

The brokers turned bullish on these ASX companies last month.

Read more »

A businessman compares the growth trajectory of property versus shares.
Share Market News

How ASX shares vs. property performed in October

The national home value rose for the 21st consecutive month while the ASX 200 dipped.

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

The worst 3 ASX 200 stocks to buy and hold in October unmasked

You would have done well to avoid these three ASX 200 stocks in October.

Read more »

A female Woolworths customer leans on her shopping trolley as she rests her chin in her hand thinking about what to buy for dinner while also wondering why the Woolworths share price isn't doing as well as Coles recently
52-Week Lows

Why is the Woolworths share price at its lowest point since 2020?

We haven't seen Woolies shares this low since COVID.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why AFT, Amcor, Corporate Travel, and Macquarie shares are falling today

These shares are ending the week in the red. But why?

Read more »